Citations 2
Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals
Snozek, Christine L.H. , Yee, Claire I., Bryksin, Janetta, Dahal, Rejwi , Gerson, Benjamin, Gherasim, Carmen , Heger, Nicholas E. , Johnson‐Davis, Kamisha L. , Knezevic, Claire E. , Love, Sara A., Noguez, Jaime H. , Pikulski, Michael, Tyagi, Manoj , Warrington, Jill S. , Yang, He S. , Yang, Yifei , Knezevic, Claire E , Roper, Stephen , Yang, Yifei K, Hauff, Kristin D. , Huestis, Marilyn Ann , Melanson, Stacy E.F. , Roper, Stephen M. , Tyagi, Manoj
American Journal of Clinical Pathology | July 27, 2024 | Volume: 163 | Issue: 1 | Pages: 69-79
Abstract Objectives Urine drug testing (UDT) is a critical tool used in medical, forensic, and occupational settings, but interpreting results can be challenging. We performed a study to assess the ability of health care professionals to interpret UDT results accurately. Methods In total, 911 clinical and laboratory professionals in the United States and Canada responded to a survey with questions gauging expertise in UDT interpretation. Responses were analyzed to identify knowledge gaps. Results Toxicologists and laboratory PhD scientists performed well, with means of 4.82 and 4.63 questions answered correctly (out of 6 possible), respectively. Physicians specializing in pathology, emergency medicine, primary care, and internal medicine, however, displayed concerning knowledge gaps, as did laboratorians with nondoctoral degrees. Experience and training correlated with interpretation accuracy. Identification of simulated compliance as well as understanding opioid exposure, metabolism, and immunoassay cross-reactivity were among the most clinically significant knowledge gaps. More than 30% of survey respondents indicated that they would seek UDT information from the internet or peers rather than clinical or laboratory experts. Conclusions The study highlighted the need for targeted education and better collaboration between clinical and laboratory experts and other health care professionals to ensure that when physicians order UDT, they can accurately interpret results and reduce harm.
Large-Scale Scientific Study Led by a Professional Organization during the COVID-19 Pandemic: Operations, Best Practices, and Lessons Learned
Ondracek, Caitlin R. , Melanson, Stacy E.F. , Doan, Loretta, Schulz, Karen , Kleinman, Stefanie, Zhao, Zhen , Kumánovics, Attila , Wu, Alan H.B. , Wiencek, Joesph R , Meng, Qing H. , Apple, Fred S. , Koch, David D., Vesper, Hubert W. , Pokuah, Fidelia, Bryksin, Janetta, Myers, Gary L., Christenson, Robert H. , Zhang, Y Victoria , Wiencek, Joesph , Ondracek, Caitlin R , Zhang, Y Victoria
The Journal of Applied Laboratory Medicine | December 7, 2023 | Volume: 9 | Issue: 2 | Pages: 371-385
Abstract In 2021, the Association for Diagnostics & Laboratory Medicine (ADLM) (formerly the American Association for Clinical Chemistry [AACC]) developed a scientific study that aimed to contribute to the understanding of SARS-CoV-2 immunity during the evolving course of the pandemic. This study was led by a group of expert member volunteers and resulted in survey data from 975 individuals and blood collection from 698 of those participants. This paper describes the formulation and execution of this large-scale scientific study, encompassing best practices and insights gained throughout the endeavor.